Third Fiscal Quarter 2026 Operational and Financial Highlights
(All comparisons are year-over-year unless otherwise noted)
- Committed Backlog of
$1.3 billion as ofJuly 31, 2026 , compared to$1.24 billion as ofJuly 31, 2025 , an increase of approximately 4.1% which includes the commitment byFit Energy USA LP (“Fit Energy”) to purchase fuel cell systems representing generation capacity of 30 MW - Added
$2.4 billion to Awarded Capacity Backlog related to Fit Energy’s option to purchase additional fuel cell systems representing generation capacity of up to 350 MW - Subsequent to the third quarter, signed the Company’s first Capacity Reservation Agreement with a major data center operator for a planned 75 MW project in
Texas , supported by an upfront reservation payment - Sales pipeline1 in Q3 2026 increased to a total of approximately 10 gigawatts (“GW”) for fiscal year 2026
- Continued work on expansion of
Torrington, CT fuel cell manufacturing facility to 500 MW of total annualized production capacity; completion expected byJune 2028 - Signed an MOU with Siemens with the goal of supporting faster, lower-cost deployment of 100+ MW commercial projects
- Delivered first two carbon capture modules to
ExxonMobil Technology and Engineering Company inRotterdam, The Netherlands in connection with the companies’ carbon capture collaboration - Revenue of
$33.0 million , compared to$46.7 million , a decrease of approximately 29% - Gross loss of
$(24.5) million , compared to$(5.1) million , an increase of approximately 377% - Loss from operations of
$(46.7) million , compared with$(95.4) million , a decrease of approximately 51% - Net loss per share attributable to common stockholders was
$(0.64) , compared with$(3.78) - Cash, cash equivalents, restricted cash and restricted cash equivalents totaled
$737.3 million
"During the third quarter,
“The expansion of our Committed and Awarded Capacity Backlog to
“Along with the increasing interest in FuelCell Energy’s power solutions, we are investing with discipline to scale our manufacturing capabilities. The expansion of our
“Demand for electricity is accelerating, driven by AI, data centers, and the broader electrification of the economy. With a growing commercial pipeline, expanding manufacturing capacity, and differentiated technology, we believe
____________________
1 Pipeline consists of ongoing commercial discussions that range from solutions discussion through contract negotiation and does not represent signed agreements. There can be no assurance that these discussions will result in executed contracts or actual sales.
Business Updates
During the third quarter,
Subsequent to the end of the third quarter,
In addition, during the third quarter, the Company advanced its production execution at, and progressed its expansion of, the
- The Company continued to increase its annualized production rate, with the goal of achieving its targeted annualized production rate of 100 MW in
October 2026 . Based on this planned increase in annualized production rate, the Company is now targeting achieving positive Adjusted EBITDA results in the fourth quarter of fiscal 2027, subject to the conversion of Awarded Capacity Backlog into Committed Backlog, customer delivery schedules and continued execution of the Company’s cost reduction initiatives. - In parallel, the Company made significant progress in resolving constraints to the annualized production capacity increase to 500 MW at the
Torrington manufacturing facility, including tape caster installation, factory design engineering, and significant purchase commitments for equipment. The expansion to 500 MW of annualized manufacturing capacity is scheduled for completion byJune 2028 .
During the quarter,
During the third quarter, the Company completed the repowering of the
Also during the third quarter, the Company reached a pivotal milestone in its multi-year joint development agreement with
Committed and Awarded Capacity Backlog
| As of | |||||||||
| (Amounts in thousands) | 2026 | 2025 | Change | ||||||
| Committed Backlog | |||||||||
| Product | $ | 108,865 | $ | 96,183 | $ | 12,682 | |||
| Service | 263,648 | 169,384 | 94,264 | ||||||
| Generation | 915,725 | 955,033 | (39,308 | ) | |||||
| Advanced Technologies | 7,772 | 24,254 | (16,482 | ) | |||||
| Total Committed Backlog | $ | 1,296,010 | $ | 1,244,854 | $ | 51,156 | |||
| Awarded Capacity Backlog | |||||||||
| Product | $ | 1,058,750 | - | $ | 1,058,750 | ||||
| Service | 1,291,500 | - | 1,291,500 | ||||||
| Total Awarded Capacity Backlog | $ | 2,350,250 | - | $ | 2,350,250 | ||||
| Total Committed and Awarded Capacity Backlog | $ | 3,646,260 | $ | 1,244,854 | $ | 2,401,406 | |||
Overall, Committed Backlog increased by approximately 4.1% to
As of
Committed Backlog represents definitive, non-cancelable agreements executed by the Company and its customers. Awarded Capacity Backlog represents commercial awards, capacity reservations, or similar customer commitments where the Company has been selected as the supplier and the parties are advancing toward execution of definitive agreements. Awarded Capacity Backlog is not included in Committed Backlog until definitive, non-cancelable agreements have been executed by both parties.
Together, the service and generation portions of Committed Backlog had a weighted average term of approximately 15 years as of
Consolidated Financial Metrics
| Three Months Ended | ||||||||||
| (Amounts in thousands, except per share data) | 2026 | 2025 | Change | |||||||
| Total revenues | $ | 33,001 | $ | 46,743 | (29 | %) | ||||
| Gross loss | (24,503 | ) | (5,134 | ) | 377 | % | ||||
| Loss from operations | (46,660 | ) | (95,364 | ) | (51 | %) | ||||
| Net loss | (45,283 | ) | (91,896 | ) | (51 | %) | ||||
| Net loss attributable to common stockholders | (45,267 | ) | (92,456 | ) | (51 | %) | ||||
| Net loss per basic and diluted share attributable to common stockholders | $ | (0.64 | ) | $ | (3.78 | ) | (83 | %) | ||
| EBITDA * | $ | (37,273 | ) | $ | (85,618 | ) | (56 | %) | ||
| Adjusted EBITDA * | $ | (36,738 | ) | $ | (16,380 | ) | 124 | % | ||
| Adjusted net loss per basic and diluted share attributable to common stockholders * | $ | (0.64 | ) | $ | (0.95 | ) | (33 | %) | ||
* Reconciliations of non-GAAP measures EBITDA, Adjusted EBITDA and Adjusted net loss per basic and diluted share attributable to common stockholders are contained in the appendix to this press release.
Third Fiscal Quarter 2026 Financial Results
(All comparisons are between third quarter of fiscal 2026 and third quarter of fiscal 2025 unless otherwise noted)
Third quarter revenue of
quarter. This was primarily due to lower product revenue resulting from fewer module deliveries to customers in
Net loss was
Net loss attributable to common stockholders was
Adjusted EBITDA totaled
The net loss per share attributable to common stockholders in the third quarter of fiscal 2026 was
Cash and Restricted Cash
Cash and cash equivalents and restricted cash and cash equivalents totaled
Sales of Common Stock
On
During the three months ended
For further information, please refer to the Company’s Quarterly Report on Form 10-Q for the quarter ended
Conference Call Information
| (1) | The live webcast of the call and supporting slide presentation will be available at www.fuelcellenergy.com. To listen to the call, select “Investors” on the home page located under the “Our Company” pull-down menu, proceed to the “Events & Presentations” page and then click on the “Webcast” link listed under the | |
| • | Alternatively, participants can dial 888-330-3181 and state | |
The replay of the conference call will be available via webcast on the Company’s Investors’ page at www.fuelcellenergy.com approximately two hours after the conclusion of the call.
Cautionary Language
This news release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 regarding future events or our future financial performance that involve certain contingencies and uncertainties. The forward-looking statements include, without limitation, statements with respect to the Company’s anticipated financial results and statements regarding the Company’s plans and expectations regarding the continuing development, commercialization and financing of its current and future fuel cell technologies, the Company’s business plans and strategies, the Company’s plan to reduce operating costs, the capabilities of the Company’s products, the Company's plans and ability to achieve positive Adjusted EBITDA, the Company’s potential sales pipeline, opportunities, and partners, and the markets in which the Company expects to operate. Projected and estimated numbers contained herein are not forecasts and may not reflect actual results. These forward-looking statements are not guarantees of future performance, and all forward-looking statements are subject to risks and uncertainties, known and unknown, that could cause actual results and future events to differ materially from those projected. Factors that could cause such a difference include, without limitation: general risks associated with product development and manufacturing; general economic conditions; changes in interest rates, which may impact project financing; supply chain disruptions; changes in the utility regulatory environment; changes in the utility industry and the markets for distributed generation, distributed hydrogen, and fuel cell power plants configured for carbon capture or carbon separation; potential volatility of commodity prices that may adversely affect our projects; availability of government subsidies and economic incentives for alternative energy technologies; our ability to remain in compliance with
About
Contact
Media Relations:
kblomquist@fce.com
203.546.5844
Investor Relations:
ir@fce.com
Consolidated Balance Sheets (Unaudited) (Amounts in thousands, except share and per share amounts) | |||||||
2026 | 2025 | ||||||
| ASSETS | |||||||
| Current assets: | |||||||
| Cash and cash equivalents, unrestricted | $ | 658,082 | $ | 278,099 | |||
| Restricted cash and cash equivalents – short-term | 24,911 | 16,601 | |||||
| Accounts receivable, net | 7,172 | 3,999 | |||||
| Unbilled receivables | 39,875 | 49,008 | |||||
| Inventories | 86,376 | 86,196 | |||||
| Other current assets | 16,885 | 15,907 | |||||
| Total current assets | 833,301 | 449,810 | |||||
| Restricted cash and cash equivalents – long-term | 54,327 | 47,092 | |||||
| Inventories – long-term | - | 3,216 | |||||
| Project assets, net | 166,588 | 216,847 | |||||
| Property, plant and equipment, net | 94,561 | 96,436 | |||||
| Operating lease right-of-use assets, net | 10,871 | 11,232 | |||||
| Intangible assets, net | 2,918 | 3,891 | |||||
| Other assets | 148,596 | 103,622 | |||||
| Total assets (1) | $ | 1,311,162 | $ | 932,146 | |||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
| Current liabilities: | |||||||
| Current portion of long-term debt | $ | 18,801 | $ | 15,847 | |||
| Current portion of operating lease liabilities | 1,007 | 932 | |||||
| Accounts payable | 16,329 | 17,009 | |||||
| Accrued liabilities | 40,531 | 31,318 | |||||
| Deferred revenue | 19,416 | 2,733 | |||||
| Total current liabilities | 96,084 | 67,839 | |||||
| Long-term deferred revenue | 14,009 | 5,985 | |||||
| Long-term operating lease liabilities | 11,638 | 11,954 | |||||
| Long-term debt and other liabilities | 146,676 | 115,227 | |||||
| Total liabilities (1) | 268,407 | 201,005 | |||||
| Redeemable Series B preferred stock (liquidation preference of | 59,857 | 59,857 | |||||
| Total equity: | |||||||
| Stockholders’ equity: Common stock ( 31, 2026 and outstanding as of | 8 | 5 | |||||
| Additional paid-in capital | 2,951,531 | 2,493,318 | |||||
| Accumulated deficit | (1,974,683 | ) | (1,829,449 | ) | |||
| Accumulated other comprehensive loss | (1,746 | ) | (1,695 | ) | |||
and | (1,577 | ) | (1,406 | ) | |||
| Deferred compensation | 1,577 | 1,406 | |||||
| Total stockholders’ equity | 975,110 | 662,179 | |||||
| Noncontrolling interests | 7,788 | 9,105 | |||||
| Total equity | 982,898 | 671,284 | |||||
| Total liabilities, redeemable Series B preferred stock and total equity | $ | 1,311,162 | $ | 932,146 | |||
| (1) | As of |
Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (Amounts in thousands, except share and per share amounts) | ||||||||||
| Three Months Ended | ||||||||||
| 2026 | 2025 | |||||||||
| Revenues: | ||||||||||
| Product | $ | 18,000 | $ | 26,000 | ||||||
| Service | 2,422 | 3,130 | ||||||||
| Generation | 8,801 | 12,355 | ||||||||
| Advanced Technologies | 3,778 | 5,258 | ||||||||
| Total revenues | 33,001 | 46,743 | ||||||||
| Costs of revenues: | ||||||||||
| Product | 37,102 | 29,083 | ||||||||
| Service | 3,776 | 3,642 | ||||||||
| Generation | 14,353 | 15,330 | ||||||||
| Advanced Technologies | 2,273 | 3,822 | ||||||||
| Total costs of revenues | 57,504 | 51,877 | ||||||||
| Gross loss | (24,503 | ) | (5,134 | ) | ||||||
| Operating expenses: | ||||||||||
| Administrative and selling expenses | 13,648 | 14,066 | ||||||||
| Research and development expenses | 8,509 | 7,646 | ||||||||
| Restructuring expense | - | 4,051 | ||||||||
| Impairment expense | - | 64,467 | ||||||||
| Total costs and expenses | 22,157 | 90,230 | ||||||||
| Loss from operations | (46,660 | ) | (95,364 | ) | ||||||
| Interest expense | (2,903 | ) | (2,548 | ) | ||||||
| Interest income | 3,573 | 2,144 | ||||||||
| Other income, net | 707 | 3,912 | ||||||||
| Loss before provision for income taxes | (45,283 | ) | (91,856 | ) | ||||||
| Provision for income taxes | - | (40 | ) | |||||||
| Net loss | (45,283 | ) | (91,896 | ) | ||||||
| Net loss attributable to noncontrolling interest | (816 | ) | (240 | ) | ||||||
| Net loss attributable to | (44,467 | ) | (91,656 | ) | ||||||
| Series B preferred stock dividends | (800 | ) | (800 | ) | ||||||
| Net loss attributable to common stockholders | $ | (45,267 | ) | $ | (92,456 | ) | ||||
| Loss per share basic and diluted: | ||||||||||
| Net loss per share attributable to common stockholders | $ | (0.64 | ) | $ | (3.78 | ) | ||||
| Basic and diluted weighted average shares outstanding | 70,405,692 | 24,441,294 | ||||||||
Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (Amounts in thousands, except share and per share amounts) | |||||||||
| Nine Months Ended | |||||||||
| 2026 | 2025 | ||||||||
| Revenues: | |||||||||
| Product | $ | 48,060 | $ | 39,099 | |||||
| Service | 9,786 | 13,122 | |||||||
| Generation | 28,470 | 35,825 | |||||||
| Advanced Technologies | 12,805 | 15,100 | |||||||
| Total revenues | 99,121 | 103,146 | |||||||
Costs of revenues: | |||||||||
| Product | 73,779 | 48,380 | |||||||
| Service | 10,087 | 14,377 | |||||||
| Generation | 50,500 | 49,035 | |||||||
| Advanced Technologies | 8,044 | 11,130 | |||||||
| Total costs of revenues | 142,410 | 122,922 | |||||||
Gross loss | (43,289 | ) | (19,776 | ) | |||||
Operating expenses: | |||||||||
| Administrative and selling expenses | 41,826 | 45,566 | |||||||
| Research and development expenses | 23,181 | 28,623 | |||||||
| Restructuring expense | - | 5,593 | |||||||
| Impairment expense | 42,567 | 64,467 | |||||||
| Total costs and expenses | 107,574 | 144,249 | |||||||
Loss from operations | (150,863 | ) | (164,025 | ) | |||||
Interest expense | (8,520 | ) | (7,703 | ) | |||||
| Interest income | 8,588 | 6,357 | |||||||
| Other income, net | 1,782 | 3,464 | |||||||
Loss before (provision for) income taxes | (149,013 | ) | (161,907 | ) | |||||
| Benefit from (provision for) income taxes | 50 | (124 | ) | ||||||
Net loss | (148,963 | ) | (162,031 | ) | |||||
| Net loss attributable to noncontrolling interest | (3,729 | ) | (4,000 | ) | |||||
| Net loss attributable to | (145,234 | ) | (158,031 | ) | |||||
| Series B preferred stock dividends | (2,400 | ) | (2,400 | ) | |||||
Net loss attributable to common stockholders | $ | (147,634 | ) | $ | (160,431 | ) | |||
Loss per share basic and diluted: | |||||||||
| Net loss per share attributable to common stockholders | $ | (2.56 | ) | $ | (7.22 | ) | |||
| Basic and diluted weighted average shares outstanding | 57,649,267 | 22,233,074 | |||||||
Appendix
Non-GAAP Financial Measures
Financial results are presented in accordance with accounting principles generally accepted in
These supplemental non-GAAP measures are provided to assist readers in assessing operating performance. Management believes EBITDA, Adjusted EBITDA, Adjusted net loss attributable to common stockholders and Adjusted net loss per share attributable to common stockholders are useful in assessing performance and highlighting trends on an overall basis. Management also believes these measures are used by companies in the fuel cell sector and by securities analysts and investors when comparing the results of the Company with those of other companies. EBITDA differs from the most comparable GAAP measure, net loss attributable to the Company, primarily because it does not include finance expense, income taxes and depreciation of property, plant and equipment and project assets. Adjusted EBITDA adjusts EBITDA for stock-based compensation, impairment and restructuring expenses, unrealized non-cash gain on natural gas derivative contracts and other unusual items, which are considered either non-cash or non-recurring. Adjusted net loss attributable to common stockholders and Adjusted net loss per share attributable to common stockholders differ from the most comparable GAAP measures, Net loss attributable to common stockholders and Net loss per share attributable to common stockholders, primarily because they do not include stock-based compensation, impairment and restructuring expenses, unrealized non-cash gain on natural gas derivative contracts and other unusual items, which are considered either non-cash or non-recurring.
While management believes that these non-GAAP financial measures provide useful supplemental information to investors, there are limitations associated with the use of these measures. The measures are not prepared in accordance with GAAP and may not be directly comparable to similarly titled measures of other companies due to differences in the exact method of calculation. The Company’s non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures and should be read only in conjunction with the Company’s consolidated financial statements prepared in accordance with GAAP.
The following table calculates EBITDA and Adjusted EBITDA and reconciles these figures to the GAAP financial statement measure Net loss.
| Three Months Ended | Nine Months Ended | |||||||||||||||||||||||
| (Amounts in thousands) | 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Net loss | $ | (45,283 | ) | $ | (91,896 | ) | (148,963 | ) | (162,031 | ) | ||||||||||||||
| Depreciation and amortization (1) | 9,387 | 9,746 | 30,747 | 30,582 | ||||||||||||||||||||
| (Benefit from) provision for income taxes | - | 40 | (50 | ) | 124 | |||||||||||||||||||
| Other income, net (2) | (707 | ) | (3,912 | ) | (1,782 | ) | (3,464 | ) | ||||||||||||||||
| Interest income | (3,573 | ) | (2,144 | ) | (8,588 | ) | (6,357 | ) | ||||||||||||||||
| Interest expense | 2,903 | 2,548 | 8,520 | 7,703 | ||||||||||||||||||||
| EBITDA | $ | (37,273 | ) | $ | (85,618 | ) | $ | (120,116 | ) | $ | (133,443 | ) | ||||||||||||
| Stock-based compensation expense | 2,452 | 1,691 | 7,472 | 8,657 | ||||||||||||||||||||
| Unrealized gain on natural gas derivative contracts (3) | (1,917 | ) | (971 | ) | (746 | ) | (2,037 | ) | ||||||||||||||||
| Impairment expense (4) | - | 64,467 | 42,567 | 64,467 | ||||||||||||||||||||
| Restructuring expense | - | 4,051 | - | 5,593 | ||||||||||||||||||||
| Adjusted EBITDA | $ | (36,738 | ) | $ | (16,380 | ) | $ | (70,823 | ) | $ | (56,763 | ) | ||||||||||||
The following table calculates Adjusted net loss attributable to common stockholders and reconciles that figure to the GAAP financial statement measure Net loss attributable to common stockholders and calculates Adjusted net loss per share attributable to common stockholders.
| Three Months Ended | Nine Months Ended | ||||||||||||||
| (Amounts in thousands except share and per share amounts) | 2026 | 2025 | 2026 | 2025 | |||||||||||
| Net loss attributable to common stockholders | $ | (45,267 | ) | $ | (92,456 | ) | (147,634 | ) | (160,431 | ) | |||||
| Stock-based compensation expense | 2,452 | 1,691 | 7,472 | 8,657 | |||||||||||
| Unrealized gain on natural gas derivative contracts (3) | (1,917 | ) | (971 | ) | (746 | ) | (2,037 | ) | |||||||
| Impairment expense (4) | - | 64,467 | 42,567 | 64,467 | |||||||||||
| Restructuring expense | - | 4,051 | - | 5,593 | |||||||||||
| Adjusted net loss attributable to common stockholders | $ | (44,732 | ) | $ | (23,218 | ) | $ | (98,341 | ) | $ | (83,751 | ) | |||
| Net loss per share attributable to common stockholders | $ | (0.64 | ) | $ | (3.78 | ) | $ | (2.56 | ) | $ | (7.22 | ) | |||
| Adjusted net loss per share attributable to common stockholders | $ | (0.64 | ) | $ | (0.95 | ) | $ | (1.71 | ) | $ | (3.77 | ) | |||
| Basic and diluted weighted average shares outstanding | 70,405,692 | 24,441,294 | 57,649,267 | 22,233,074 | |||||||||||
| (1) | Includes depreciation and amortization on our Generation portfolio of |
| (2) | Other income, net includes gains and losses from transactions denominated in foreign currencies, interest rate swap income earned from investments and other items incurred periodically, which are not the result of the Company’s normal business operations. |
| (3) | The Company recorded mark-to-market net gains of |
| (4) | The Company recorded a non-cash impairment expense of |
Source: 